Your browser doesn't support javascript.
loading
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors.
Eads, Jennifer R; Krishnamurthi, Smitha S; Saltzman, Joel; Bokar, Joseph A; Savvides, Panos; Meropol, Neal J; Gibbons, Joseph; Koon, Henry; Sharma, Neelesh; Rogers, Lisa; Pink, John J; Xu, Yan; Beumer, Jan H; Riendeau, John; Fu, Pingfu; Gerson, Stanton L; Dowlati, Afshin.
Afiliación
  • Eads JR; Case Comprehensive Cancer Center, Case Western Reserve University, University Hospitals Seidman Cancer Center, 11100 Euclid Avenue, Lakeside 1200, Cleveland, OH, 44106, USA.
  • Krishnamurthi SS; Case Comprehensive Cancer Center, Case Western Reserve University, University Hospitals Seidman Cancer Center, 11100 Euclid Avenue, Lakeside 1200, Cleveland, OH, 44106, USA.
  • Saltzman J; Case Comprehensive Cancer Center, Case Western Reserve University, University Hospitals Seidman Cancer Center, 11100 Euclid Avenue, Lakeside 1200, Cleveland, OH, 44106, USA.
  • Bokar JA; Case Comprehensive Cancer Center, Case Western Reserve University, University Hospitals Seidman Cancer Center, 11100 Euclid Avenue, Lakeside 1200, Cleveland, OH, 44106, USA.
  • Savvides P; St. Joseph's Hospital and Medical Center, University of Arizona Comprehensive Cancer Center, University of Arizona, Phoenix, AZ, USA.
  • Meropol NJ; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Gibbons J; Flatiron Health, New York, NY, USA.
  • Koon H; Case Comprehensive Cancer Center, Case Western Reserve University, University Hospitals Seidman Cancer Center, 11100 Euclid Avenue, Lakeside 1200, Cleveland, OH, 44106, USA.
  • Sharma N; Case Comprehensive Cancer Center, Case Western Reserve University, University Hospitals Seidman Cancer Center, 11100 Euclid Avenue, Lakeside 1200, Cleveland, OH, 44106, USA.
  • Rogers L; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Pink JJ; Case Comprehensive Cancer Center, Case Western Reserve University, University Hospitals Seidman Cancer Center, 11100 Euclid Avenue, Lakeside 1200, Cleveland, OH, 44106, USA.
  • Xu Y; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Beumer JH; Case Comprehensive Cancer Center, Cleveland State University, Cleveland, OH, USA.
  • Riendeau J; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Fu P; Case Comprehensive Cancer Center, Case Western Reserve University, University Hospitals Seidman Cancer Center, 11100 Euclid Avenue, Lakeside 1200, Cleveland, OH, 44106, USA.
  • Gerson SL; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Dowlati A; Case Comprehensive Cancer Center, Case Western Reserve University, University Hospitals Seidman Cancer Center, 11100 Euclid Avenue, Lakeside 1200, Cleveland, OH, 44106, USA.
Invest New Drugs ; 39(1): 142-151, 2021 02.
Article en En | MEDLINE | ID: mdl-32556884
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antineoplásicos Alquilantes / Temozolomida / Hidroxilaminas / Neoplasias Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antineoplásicos Alquilantes / Temozolomida / Hidroxilaminas / Neoplasias Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos